NDC Pharmacologic Class N0000009319 Increased Erythroid Cell Production [PE]

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
0069-1305Retacrit Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1306Retacrit Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1307Retacrit Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1308Retacrit Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncHuman Prescription Drug
0069-1309Retacrit Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousPfizer Laboratories Div Pfizer IncHuman Prescription Drug
55513-002Aranesp Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-003Aranesp Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-004Aranesp Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-005Aranesp Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-006Aranesp Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-021Aranesp Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-023Aranesp Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-025Aranesp Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-027Aranesp Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-028Aranesp Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-032Aranesp Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-057Aranesp Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-098Aranesp Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-110Aranesp Darbepoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-111Aranesp Darbepoetin AlfaInjection, SolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-126Epogen Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-144Epogen Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-148Epogen Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-267Epogen Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-283Epogen Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
55513-478Epogen Epoetin AlfaSolutionIntravenous; SubcutaneousAmgen IncHuman Prescription Drug
59353-002Retacrit Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.Human Prescription Drug
59353-003Retacrit Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.Human Prescription Drug
59353-004Retacrit Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.Human Prescription Drug
59353-010Retacrit Epoetin Alfa-epbxInjection, SolutionIntravenous; SubcutaneousVifor (international) Inc.Human Prescription Drug
59353-400Mircera Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.Human Prescription Drug
59353-401Mircera Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.Human Prescription Drug
59353-402Mircera Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.Human Prescription Drug
59353-403Mircera Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.Human Prescription Drug
59353-404Mircera Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.Human Prescription Drug
59353-405Mircera Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.Human Prescription Drug
59353-406Mircera Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.Human Prescription Drug
59353-407Mircera Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.Human Prescription Drug
59353-408Mircera Methoxy Polyethylene Glycol-epoetin BetaInjection, SolutionIntravenousVifor (international) Inc.Human Prescription Drug
59676-302Procrit ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpHuman Prescription Drug
59676-303Procrit ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpHuman Prescription Drug
59676-304Procrit ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpHuman Prescription Drug
59676-310Procrit ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpHuman Prescription Drug
59676-312Procrit ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpHuman Prescription Drug
59676-320Procrit ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpHuman Prescription Drug
59676-340Procrit ErythropoietinInjection, SolutionIntravenous; SubcutaneousJanssen Products, LpHuman Prescription Drug

There are 46 NDC products with the pharmacologic class Increased Erythroid Cell Production [PE].